Literature DB >> 19456822

Hepatitis B virus subgenotype C2 is the most prevalent subgenotype in northeast China.

H Y Wang1, D Li, W Liu, X Jin, B Du, Y P Li, H X Gu, S Y Zhang.   

Abstract

The geographical distribution of hepatitis B virus (HBV) subgenotypes and their clinical implications in patients with acute and chronic hepatitis B in the Heilung-kiang province of northeast China were investigated. Nested PCR and multiplex PCR were performed with genotype-specific primers and with subgenotype-specific primers to identify genotypes and subgenotypes from serum samples of 412 HBV infections including 69 with acute self-limited hepatitis (ASH) and 343 with chronic hepatitis (CH). A total of 361 samples were genotyped and 304 were further subgenotyped. The most common HBV genotype was C (93.63%, 338/361), with subgenotype group C2 (83.73%, 283/338) predominating. Genotype B was also found and subgenotype B2 predominated within this genotype. Out of 69 infected patients with ASH, 48 were identified as genotype C and all belonged to subgenotype C2. Of 343 infected patients with CH, 313 were genotyped and 256 were subgenotyped; amongst these, C2 (91.80%, 235/256), B2 (7.42%, 19/256) and mixed subgenotypes B2 and C2 (0.78%, 2/256) were found. In HBV subgenotype C2 infections, ASH had a higher ratio of women than CH patients. These results show that HBV subgenotypes C2 and B2 were found in Heilung-kiang province of northeast China. In ASH and CH groups, the distributions of subgenotypes were coincident with C2, the predominant subgenotype. Analysis of the association between subgenotype and the outcomes of HBV infection was inconclusive in our study.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19456822     DOI: 10.1111/j.1469-0691.2009.02834.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  5 in total

1.  Hepatitis B virus (HBV) subgenotypes C2 and B2 differ in lamivudine- and adefovir-resistance-associated mutational patterns in HBV-infected Chinese patients.

Authors:  Xiaodong Li; Lin Wang; Yanwei Zhong; Vincent Wai-Sun Wong; Zhihui Xu; Yan Liu; Qinghong Li; Shaojie Xin; Jingmin Zhao; Dongping Xu
Journal:  J Clin Microbiol       Date:  2010-09-29       Impact factor: 5.948

Review 2.  Hepatitis B virus burden in developing countries.

Authors:  Rosa Zampino; Adriana Boemio; Caterina Sagnelli; Loredana Alessio; Luigi Elio Adinolfi; Evangelista Sagnelli; Nicola Coppola
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

Review 3.  The global burden of liver disease: the major impact of China.

Authors:  Fu-Sheng Wang; Jian-Gao Fan; Zheng Zhang; Bin Gao; Hong-Yang Wang
Journal:  Hepatology       Date:  2014-10-29       Impact factor: 17.425

4.  High prevalence of the B2+C2 subgenotype mixture in patients with chronic hepatitis B in Eastern China.

Authors:  Jun Zhong; Yue-Qiu Gao; Xue-Hua Sun; Xiao-Jun Zhu; Man Li
Journal:  Acta Pharmacol Sin       Date:  2012-09-03       Impact factor: 6.150

5.  Association of human leukocyte antigen haplotypes with clearance and persistence of hepatitis B virus infection in northeastern China.

Authors:  H Y Wang; F Wang; M Cheng; Y Liu; S Y Zhang
Journal:  Epidemiol Infect       Date:  2015-01-16       Impact factor: 4.434

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.